BSE and NSE have approved the merger of Ranbaxy Laboratories with Sun Pharmaceutical clearing a at regulatory hurdle facing consummation of the pharma deal.

Report stated that the approval of the BSE and the NSE will allow Sun Pharma to delist Ranbaxy shares from the two exchanges.

The exchanges approved the $4-billion merger deal last week. There are reports that the two companies will need clearances of the high courts of Gujarat and Punjab & Haryana.

Source: IIFL

Like

Dislike

Be a part of Elets Collaborative Initiatives. Join Us for Upcoming Events and explore business opportunities. Like us on Facebook , connect with us on LinkedIn and follow us on Twitter , Instagram.